Clinical Trial Update: Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Pharmacogenomic Decision Support with GeneSight Psychotropic to guide treatment of major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder

Snippet

Sponsor: Assurex Health Inc. | Conditions: Depressive Disorder, Major, Depression | Phase 4 | Status: COMPLETED